Evidence map›Paper›PMID 22829776›Full record

SynthesisPLoS genetics2012

A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation.

Andrea D Coviello, Robin Haring, Melissa Wellons, Dhananjay Vaidya, Terho Lehtimäki, Sarah Keildson, Kathryn L Lunetta, Chunyan He, Myriam Fornage, Vasiliki Lagou and 89 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PLoS genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 3 pooled it
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 3 syntheses or guidelines pooled it, 255 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Genetic Variation in Steroid and Xenobiotic Metabolizing Pathways and Enterolactone Excretion Before and After Flaxseed Intervention in African American and European American Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

99 authors at 20 institutions in 9 countries.

Andrea D CovielloSection of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Robin Haring
Melissa Wellons
Dhananjay Vaidya
Terho Lehtimäki
Sarah Keildson
Kathryn L Lunetta
Chunyan He
Myriam Fornage
Vasiliki Lagou
Massimo Mangino
N Charlotte Onland-Moret
Brian Chen
Joel Eriksson
Melissa Garcia
Yong Mei Liu
Annemarie Koster
Kurt Lohman
Leo-Pekka Lyytikäinen
Ann-Kristin Petersen
Jennifer Prescott
Lisette Stolk
Liesbeth Vandenput
Andrew R Wood
Wei Vivian Zhuang
Aimo Ruokonen
Anna-Liisa Hartikainen
Anneli Pouta
Stefania Bandinelli
Reiner Biffar
Georg Brabant
David G Cox
Yuhui Chen
Steven Cummings
Luigi Ferrucci
Marc J Gunter
Susan E Hankinson
Hannu Martikainen
Albert Hofman
Georg Homuth
Thomas Illig
John-Olov Jansson
Andrew D Johnson
David Karasik
Magnus Karlsson
Johannes Kettunen
Douglas P Kiel
Peter Kraft
Jingmin Liu
Östen Ljunggren
Mattias Lorentzon
Marcello Maggio
Marcello R P Markus
Dan Mellström
Iva Miljkovic
Daniel Mirel
Sarah Nelson
Laure Morin Papunen
Petra H M Peeters
Inga Prokopenko
Leslie Raffel
Martin Reincke
Alex P Reiner
Kathryn Rexrode
Fernando Rivadeneira
Stephen M Schwartz
David Siscovick
Nicole Soranzo
Doris Stöckl
Shelley Tworoger
André G Uitterlinden
Carla H van Gils
Ramachandran S Vasan
H-Erich Wichmann
Guangju Zhai
Shalender Bhasin
Martin Bidlingmaier
Stephen J Chanock
Immaculata De Vivo
Tamara B Harris
David J Hunter
Mika Kähönen
Simin Liu
Pamela Ouyang
Tim D Spector
Yvonne T van der Schouw
Jorma Viikari
Henri Wallaschofski
Mark I McCarthy
Timothy M Frayling
Anna Murray
Steve Franks
Marjo-Riitta Järvelin
Frank H de Jong
Olli Raitakari
Alexander Teumer
Claes Ohlsson
Joanne M Murabito
John R B Perry
University of Gothenburg · SEUniversität Greifswald · DEHarvard University · USNational Institute on Aging · USUniversity Medical Center Utrecht · NLBoston University · USBrigham and Women's Hospital · USHelmholtz Zentrum München · DEKing's College London · GBNational Heart Lung and Blood Institute · USOulu University Hospital · FIUniversity of Exeter · GBUniversity of Oulu · FIUniversity of Oxford · GBUniversity of Washington · USErasmus MC · NLErasmus University Rotterdam · NLHebrew SeniorLife · USImperial College London · GBJohns Hopkins University · US

Funding

Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TWOROGER, SHELLEY S · 2000 to 2019
$77.8M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
A Center for GEI Association StudiesU01HG004424 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY · 2007 to 2010
$21.4M
RISK FACTORS FOR VERTEBRAL FRACTURE AND BONE LOSSR01AR041398 · NIAMS · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI KIEL, DOUGLAS P. · 1991 to 2025
$16.1M
AN NCRR CENTER FOR HIGH THROUGHPUT SNP GENOTYPING AND ANALYSIS: GAIN NETWORKU54RR020278 · NCRR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY · 2004 to 2008
$14.4M
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORTR01CA049449 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HANKINSON, SUSAN E · 1989 to 2008
$11.3M
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3U01CA098233 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNTER, DAVID JOHN · 2003 to 2010
$10.8M
CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
STATISTICAL METHODS FOR GENE MAPPINGR01GM053275 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LANGE, KENNETH L · 1995 to 2019
$9.3M
Genome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6M
Biotechnology and Biological Sciences Research Council G20234Intramural NIH HHSMedical Research Council G0500539Medical Research Council G0600705Medical Research Council G0802782Medical Research Council QLG1-CT-2000-01643NCI NIH HHS CA128034NCI NIH HHS CA40356NCI NIH HHS CA49449NCI NIH HHS CA87969NCI NIH HHS P01 CA087969NCI NIH HHS R01 CA040356NCI NIH HHS R01 CA049449NCI NIH HHS R03 CA128034NCI NIH HHS U01 CA049449NCI NIH HHS U01 CA098233NCI NIH HHS U01-CA98233NCRR NIH HHS RR-024156NCRR NIH HHS U54 RR020278NCRR NIH HHS UL1 RR024156NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004424NHGRI NIH HHS U01-HG-004424NHGRI NIH HHS U01 HG004446NHGRI NIH HHS U01-HG-004446NHGRI NIH HHS U01 HG004729NHGRI NIH HHS U01-HG-004729NHGRI NIH HHS U01 HG005152NHLBI NIH HHS 5-K23-HL087114NHLBI NIH HHS 5R01HL087679-02NHLBI NIH HHS HL074338NHLBI NIH HHS HL074406NHLBI NIH HHS HL087679NHLBI NIH HHS K23 HL087114NHLBI NIH HHS N01 HC005187NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01 HC045134NHLBI NIH HHS N01 HC045204NHLBI NIH HHS N01 HC045205NHLBI NIH HHS N01 HC048047NHLBI NIH HHS N01 HC048048NHLBI NIH HHS N01 HC048049NHLBI NIH HHS N01 HC048050NHLBI NIH HHS N01-HC-05187NHLBI NIH HHS N01 HC095095NHLBI NIH HHS N01 HC095159NHLBI NIH HHS N01 HC095160NHLBI NIH HHS N01 HC095161NHLBI NIH HHS N01 HC095162NHLBI NIH HHS N01 HC095163NHLBI NIH HHS N01 HC095164NHLBI NIH HHS N01 HC095165NHLBI NIH HHS N01 HC095166NHLBI NIH HHS N01 HC095167NHLBI NIH HHS N01 HC095168NHLBI NIH HHS N01 HC095169NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS N01-HC-45204NHLBI NIH HHS N01-HC-45205NHLBI NIH HHS N01-HC-48047NHLBI NIH HHS N01-HC-48048NHLBI NIH HHS N01-HC-48049NHLBI NIH HHS N01-HC-48050NHLBI NIH HHS N01-HC-95095NHLBI NIH HHS N01 HC-95159NHLBI NIH HHS N01-HC-95160NHLBI NIH HHS N01-HC-95161NHLBI NIH HHS N01-HC-95162NHLBI NIH HHS N01-HC-95163NHLBI NIH HHS N01-HC-95164NHLBI NIH HHS N01-HC-95165NHLBI NIH HHS N01-HC-95166NHLBI NIH HHS N01-HC-95167NHLBI NIH HHS N01-HC-95168NHLBI NIH HHS N01-HC-95169NHLBI NIH HHS N02-HL-6-4278NHLBI NIH HHS R01 HL065611NHLBI NIH HHS R01-HL065611NHLBI NIH HHS R01 HL074338NHLBI NIH HHS R01 HL074406NHLBI NIH HHS R01 HL084099NHLBI NIH HHS R01-HL-084099NHLBI NIH HHS R01 HL087679NHLBI NIH HHS R01 HL094755NHLBI NIH HHS R01HL094755NIAMS NIH HHS AR 41398NIAMS NIH HHS R01 AR041398NIA NIH HHS 1-AG-1-2111NIA NIH HHS 1R01AG032098-01A1NIA NIH HHS N01 AG062101NIA NIH HHS N01 AG062103NIA NIH HHS N01 AG062106NIA NIH HHS N01-AG-5-0002NIA NIH HHS N.1-AG-1-1NIA NIH HHS R01 AG031206NIA NIH HHS R01 AG032098NIA NIH HHS R01AG31206NIA NIH HHS R21 AG032598NIA NIH HHS R21AG032598NIGMS NIH HHS GM053275-14NIGMS NIH HHS R01 GM053275NIMHD NIH HHS 263 MD 821336NIMHD NIH HHS 263 MD 9164NIMHD NIH HHS R01 MD009164NIMH NIH HHS 1RL1MH083268-01NIMH NIH HHS 5R01MH63706NIMH NIH HHS MH083268NIMH NIH HHS R01 MH063706NIMH NIH HHS RL1 MH083268PHS HHS 24152PHS HHS 32100-2PHS HHS 32105-6PHS HHS 32108-9PHS HHS 32111-13PHS HHS 32115PHS HHS 32118-32119PHS HHS 32122PHS HHS 41071PHS HHS 42107-26PHS HHS 42129-32PHS HHS 44221PHS HHS NFBC1966Wellcome Trust 090532Wellcome Trust GR069224WHI NIH HHS N01 WH022110
6 · The paper itself

Abstract

Sex hormone-binding globulin (SHBG) is a glycoprotein responsible for the transport and biologic availability of sex steroid hormones, primarily testosterone and estradiol. SHBG has been associated with chronic diseases including type 2 diabetes (T2D) and with hormone-sensitive cancers such as breast and prostate cancer. We performed a genome-wide association study (GWAS) meta-analysis of 21,791 individuals from 10 epidemiologic studies and validated these findings in 7,046 individuals in an additional six studies. We identified twelve genomic regions (SNPs) associated with circulating SHBG concentrations. Loci near the identified SNPs included SHBG (rs12150660, 17p13.1, p = 1.8 × 10(-106)), PRMT6 (rs17496332, 1p13.3, p = 1.4 × 10(-11)), GCKR (rs780093, 2p23.3, p = 2.2 × 10(-16)), ZBTB10 (rs440837, 8q21.13, p = 3.4 × 10(-09)), JMJD1C (rs7910927, 10q21.3, p = 6.1 × 10(-35)), SLCO1B1 (rs4149056, 12p12.1, p = 1.9 × 10(-08)), NR2F2 (rs8023580, 15q26.2, p = 8.3 × 10(-12)), ZNF652 (rs2411984, 17q21.32, p = 3.5 × 10(-14)), TDGF3 (rs1573036, Xq22.3, p = 4.1 × 10(-14)), LHCGR (rs10454142, 2p16.3, p = 1.3 × 10(-07)), BAIAP2L1 (rs3779195, 7q21.3, p = 2.7 × 10(-08)), and UGT2B15 (rs293428, 4q13.2, p = 5.5 × 10(-06)). These genes encompass multiple biologic pathways, including hepatic function, lipid metabolism, carbohydrate metabolism and T2D, androgen and estrogen receptor function, epigenetic effects, and the biology of sex steroid hormone-responsive cancers including breast and prostate cancer. We found evidence of sex-differentiated genetic influences on SHBG. In a sex-specific GWAS, the loci 4q13.2-UGT2B15 was significant in men only (men p = 2.5 × 10(-08), women p = 0.66, heterogeneity p = 0.003). Additionally, three loci showed strong sex-differentiated effects: 17p13.1-SHBG and Xq22.3-TDGF3 were stronger in men, whereas 8q21.12-ZBTB10 was stronger in women. Conditional analyses identified additional signals at the SHBG gene that together almost double the proportion of variance explained at the locus. Using an independent study of 1,129 individuals, all SNPs identified in the overall or sex-differentiated or conditional analyses explained ~15.6% and ~8.4% of the genetic variation of SHBG concentrations in men and women, respectively. The evidence for sex-differentiated effects and allelic heterogeneity highlight the importance of considering these features when estimating complex trait variance.

Indexed as

Genome-Wide Association StudyAllelesFemaleGenetic HeterogeneityGonadal Steroid HormonesHumansMaleMetabolic Networks and PathwaysPolymorphism, Single NucleotideSex CharacteristicsSex Hormone-Binding GlobulinGonadal Steroid HormonesSex Hormone-Binding Globulin

Identifiers

PMID22829776
PMCPMC3400553
OpenAlexW2134471459

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.